U.S. Neurology Associates

Private

Dallas, TexasHealthcare & Life Scienceshttps://usneuroassoc.com/

Last Round

Growth Equity

Jan 9, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

U.S. Neurology Associates is a healthcare services company that provides administrative, operational, and strategic support to community-based neurology practices to enhance patient care and practice growth.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Revenue Cycle, Medical Imaging, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Revenue Share

AI Layer

Non-AI

Keywords

physician services organizationPSOpractice managementneurology practice managementrevenue cycle managementRCMvalue-based careVBCMSOmedical practice roll-uppayer contractingspecialty pharmacyin-office infusiondiagnostic imagingclinical trialshealthcare consolidation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

U.S. Neurology Associates Comparables

Compare U.S. Neurology Associates with similar companies based on industry and business-model similarity.

U.S. Neurology Associates comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Autonomy Health	88%
PracticeCore	76%
United Musculoskeletal Partners	68%

View all Comparables

U.S. Neurology Associates Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Growth Equity	Jan 9, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Nitin Jain

CEO and Co-Founder

Founding Team

U.S. Neurology Associates Investors

Notable investors and investment history

U.S. Neurology Associates investors
Investor	Rounds
M33 Growth	Growth Equity

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 9, 2026
Raised Growth Equity round led by M33 Growth.

View all signals

U.S. Neurology Associates Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

U.S. Neurology Associates Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about U.S. Neurology Associates's valuation, stock price, and market status.

Firmographic Details

HeadquartersDallas, Texas

Employee Range3

Year Founded2025

Last FundingJan 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.